Eisai Stock News
¥4,662.00
0.30%
Tokyo, Oct 07, 02:49 pm JST.
Closed.
Industry
Eisai Stock News
The U.S. FDA on Monday approved an at-home starting dose of Eisai's and Biogen's Alzheimer's drug, allowing some patients to begin therapy with injections administered by themselves or a caregiver.
The leaders of Britain and Japan announced a tech partnership on Sunday designed to boost national security and create jobs, and pledged to speed up the progress of their next generation fighter jet, GCAP.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
